PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Neurology Outpatient Clinic, De Boelelaan 1118, 1081 HV, Amsterdam, the Netherlands. Electronic address: a.toorop@amsterdamumc.nl.\', \'Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Neurology Outpatient Clinic, De Boelelaan 1118, 1081 HV, Amsterdam, the Netherlands.\', \'Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.\', \'Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, MS Center Amsterdam, Amsterdam, the Netherlands; Queen Square MS Center, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, United Kingdom,; National Institute for Health Research (NIHR), University College London Hospitals (UCLH), Biomedical Research Center, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2211-0348(21)00631-310.1016/j.msard.2021.103364
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 35158470
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • The wearing-off phenomenon of ocrelizumab in patients with multiple sclerosis.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all